Aromatized liposomes for sustained drug delivery.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
20 10 2023
Historique:
received: 01 11 2022
accepted: 25 09 2023
medline: 1 11 2023
pubmed: 21 10 2023
entrez: 20 10 2023
Statut: epublish

Résumé

Insufficient drug loading and leakage of payload remain major challenges in designing liposome-based drug delivery systems. These phenomena can limit duration of effect and cause toxicity. Targeting the rate-limiting step in drug release from liposomes, we modify (aromatized) them to have aromatic groups within their lipid bilayers. Aromatized liposomes are designed with synthetic phospholipids with aromatic groups covalently conjugated onto acyl chains. The optimized aromatized liposome increases drug loading and significantly decreases the burst release of a broad range of payloads (small molecules and macromolecules, different degrees of hydrophilicity) and extends their duration of release. Aromatized liposomes encapsulating the anesthetic tetrodotoxin (TTX) achieve markedly prolonged effect and decreased toxicity in an application where liposomes are used clinically: local anesthesia, even though TTX is a hydrophilic small molecule which is typically difficult to encapsulate. Aromatization of lipid bilayers can improve the performance of liposomal drug delivery systems.

Identifiants

pubmed: 37863880
doi: 10.1038/s41467-023-41946-8
pii: 10.1038/s41467-023-41946-8
pmc: PMC10589217
doi:

Substances chimiques

Liposomes 0
Lipid Bilayers 0
Phospholipids 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6659

Informations de copyright

© 2023. Springer Nature Limited.

Références

J Control Release. 2001 Jun 15;73(2-3):121-36
pubmed: 11516493
Nano Lett. 2017 Feb 8;17(2):660-665
pubmed: 28058845
N Engl J Med. 2016 Apr 14;374(15):1480-5
pubmed: 26845291
Nat Rev Chem. 2017 Aug;1(8):
pubmed: 31286060
Pain. 2003 Jul;104(1-2):415-21
pubmed: 12855352
Anesthesiology. 1998 Jul;89(1):119-31
pubmed: 9667302
Regul Toxicol Pharmacol. 1981 Jun;1(1):90-109
pubmed: 6764550
J Am Chem Soc. 2008 Nov 19;130(46):15702-12
pubmed: 18950160
J Surg Res. 2021 Aug;264:510-533
pubmed: 33862580
ACS Appl Mater Interfaces. 2019 Oct 16;11(41):37411-37420
pubmed: 31556583
Reg Anesth Pain Med. 2004 Jul-Aug;29(4):333-40
pubmed: 15305253
Nano Lett. 2016 Jan 13;16(1):177-81
pubmed: 26654461
Langmuir. 2019 May 7;35(18):6064-6074
pubmed: 30977658
Clin Ther. 2013 Mar;35(3):312-320.e5
pubmed: 23453403
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7125-30
pubmed: 19365067
Anesthesiology. 2008 May;108(5):921-8
pubmed: 18431129
Nano Lett. 2018 Jan 10;18(1):32-37
pubmed: 29227106
Toxicon. 1999 Jan;37(1):145-58
pubmed: 9920486
Anesth Analg. 2018 Apr;126(4):1170-1175
pubmed: 29239940
Chem Soc Rev. 2014 Dec 7;43(23):8150-77
pubmed: 25199102
Adv Drug Deliv Rev. 2020;154-155:2-12
pubmed: 32707149
Nat Biomed Eng. 2017;1:644-653
pubmed: 29152410
Pharmaceutics. 2017 Mar 27;9(2):
pubmed: 28346375
Biotechnol Bioeng. 2007 Feb 1;96(2):203-9
pubmed: 17191251
J Control Release. 2014 Sep 28;190:274-87
pubmed: 24816069
Mater Today (Kidlington). 2017 Jan-Feb;20(1):22-31
pubmed: 28970739
Front Microbiol. 2017 Aug 22;8:1550
pubmed: 28878741
Somatosens Mot Res. 1994;11(3):243-57
pubmed: 7887056
Environ Health Perspect. 2007 Jan;115(1):93-101
pubmed: 17366826
Environ Int. 2020 Jun;139:105692
pubmed: 32251899
Biochim Biophys Acta. 2016 Oct;1858(10):2254-2265
pubmed: 27085977
Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):4465-4470
pubmed: 29626132
Anesth Analg. 2013 Apr;116(4):794-803
pubmed: 23460564
Nat Biomed Eng. 2021 Sep;5(9):1099-1109
pubmed: 34518656
J Biomed Mater Res A. 2006 May;77(2):351-61
pubmed: 16425240
Proc Natl Acad Sci U S A. 2015 Dec 22;112(51):15719-24
pubmed: 26644576
Nat Mater. 2011 Mar;10(3):243-51
pubmed: 21336265
Nat Mater. 2011 Apr;10(4):324-32
pubmed: 21423187
Nat Rev Drug Discov. 2005 Feb;4(2):145-60
pubmed: 15688077
Biomaterials. 2014 May;35(15):4557-64
pubmed: 24612918
Adv Drug Deliv Rev. 2013 Jan;65(1):36-48
pubmed: 23036225

Auteurs

Yang Li (Y)

Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA, 02115, US.

Tianjiao Ji (T)

Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA, 02115, US.

Matthew Torre (M)

Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, US.

Rachelle Shao (R)

Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA, 02115, US.

Yueqin Zheng (Y)

Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA, 02115, US.

Dali Wang (D)

Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA, 02115, US.

Xiyu Li (X)

Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA, 02115, US.

Andong Liu (A)

Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA, 02115, US.

Wei Zhang (W)

Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA, 02115, US.

Xiaoran Deng (X)

Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA, 02115, US.

Ran Yan (R)

Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA, 02115, US.

Daniel S Kohane (DS)

Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA, 02115, US. daniel.kohane@childrens.harvard.edu.

Articles similaires

Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.

Prashant Kesharwani, Kratika Halwai, Saurav Kumar Jha et al.
1.00
Chitosan Humans Folic Acid Nanoparticles Drug Carriers
Administration, Intranasal Humans Animals Nasal Mucosa Brain
Escherichia coli Membrane Fluidity Temperature Escherichia coli Proteins Fatty Acids

Classifications MeSH